Genetic and clinical biomarkers of tocilizumab response in patients with rheumatoid arthritis. [electronic resource]
Producer: 20180105Description: 264-271 p. digitalISSN:- 1096-1186
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Humanized -- adverse effects
- Antigens, CD -- genetics
- Antigens, Differentiation, T-Lymphocyte -- genetics
- Antirheumatic Agents -- adverse effects
- Arthritis, Rheumatoid -- blood
- Chi-Square Distribution
- Female
- Gene Frequency
- Genome-Wide Association Study
- Heterozygote
- Homozygote
- Humans
- Lectins, C-Type -- genetics
- Linear Models
- Logistic Models
- Male
- Middle Aged
- Multivariate Analysis
- N-Acetylgalactosaminyltransferases -- genetics
- Odds Ratio
- Pharmacogenetics
- Pharmacogenomic Testing
- Pharmacogenomic Variants
- Phenotype
- Predictive Value of Tests
- Recovery of Function
- Remission Induction
- Retrospective Studies
- Risk Factors
- Treatment Outcome
- Young Adult
- Polypeptide N-acetylgalactosaminyltransferase
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.